Home › Blood Cancers › Texas › Austin
Blood Cancers clinical trials in Austin, TX
3 studies for Blood Cancers are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RecruitingPhase 3
- Texas Oncology - Central/South Texas ( Site 8001), Austin
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- Texas Oncology-Austin Midtown, Austin
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- Sarah Cannon Research Institute - St. David's South Austin Medical Center / Texas Oncology South Austin, Austin
Blood Cancers trials in other cities
- Houston, TX46 studies
- New York City, NY26 studies
- Boston, MA25 studies
- Washington, DC19 studies
- Baltimore, MD18 studies
- Seattle, WA18 studies
- Los Angeles, CA17 studies
- Durham, NC16 studies
- Chicago, IL15 studies
- Edison, NJ14 studies
- Philadelphia, PA14 studies
- Nashville, TN13 studies
Other studies in Austin
- Non-Small Cell Lung Cancer30 studies
- Cancer (all types)21 studies
- Obesity20 studies
- Colorectal Cancer19 studies
- Metastatic Cancer19 studies
- Heart Failure18 studies
- Overweight18 studies
- Breast Cancer18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer16 studies
- Prostate Cancer15 studies
- Depression14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.